Clinical Trial Update: Decitabine Combined With Unrelated Cord Blood Transplantation for Elderly Patients With AML [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating decitabine with unrelated cord blood transplantation in elderly patients with acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: Ruijin Hospital | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: UNKNOWN